Product Features Name: Retatrutide Concentration: 20 mg Form: Lyophilized (freeze-dried) powder Purity: 99% (HPLC verified) Molecular formula: CHNO Molecular weight: ~6473.2 g/mol CAS number: 2381089-83-2 Receptor activity: GLP-1 / GIP / GCGR agonist Applications in research Retatrutide is widely used in research projects aimed at: The role of incretin hormones in metabolic processes Energy consumption and fat metabolism Regulation of appetite and satiety mechanisms Innovative strategies within metabolic and endocrine research Packaging and storage Contents: 1 vial of Retatrutide 20 mg Storage advice: Store in a cool, dry place (2-8 C), protected from light Why choose Retatrutide 20 mg
Retatrutide also represents a new class of drugs that could have broad applications, further expanding Eli Lilly's market opportunity
Aging Cell (2013) 12(2):292302
Prices typically run $150-400 CAD monthly depending on the compound and dosage requirements
And current data reiterates the potential benefits of GLP-1 drugs for weight loss, with a recent study finding that medications like Wegovy that are prescribed for weight loss may reduce the risk of heart attack, stroke or heart-related death in people with cardiovascular disease
Indirect comparisons suggest that, in terms of side effects, retatrutide may be most similar to the triple-strength, 7.2 mg Wegovy dose that the FDA approved in 2026